BDO:PSEBDO Unibank, Inc. Analysis
Data as of 2026-08-18 - not real-time
€3.08
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Clarus Corporation trades at €3.08, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. The last 30 days have gained 11.6%. RSI sits at 56.3, which reads as neutral, and MACD momentum is bullish. Recent trading has carved out support near €2.78 and resistance around €3.30.
Multiples put this in undervalued territory at a P/E of 2.1. The 2.68% dividend yield looks covered by current payout levels.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 43.8%, a beta of 0.01 and a maximum drawdown of 36.7%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on buy — conviction 4 out of 10.
Multiples put this in undervalued territory at a P/E of 2.1. The 2.68% dividend yield looks covered by current payout levels.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 43.8%, a beta of 0.01 and a maximum drawdown of 36.7%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on buy — conviction 4 out of 10.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 2.74
- MACD momentum is positive
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 2.74
- 30-day volatility of 43.8%
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- Negative profit margin of -12.4%
- Negative return on equity of -14.9%
- P/E ratio of 2.1
Key Metrics & Analysis
Financial Health
Revenue Growth1.60%
Profit Margin-12.44%
P/E Ratio2.1
ROE-14.87%
ROA-2.23%
Debt/Equity8.66
P/B Ratio0.7
Op. Cash Flow€4.4M
Free Cash Flow€11.7M
Technical Analysis
TrendBullish
RSI56.3
Support€2.78
Resistance€3.30
MA 20€2.98
MA 50€2.83
MA 200€2.74
MACDBullish
VolumeStable
Fear & Greed Index92.82
Valuation
Fair Value€4.51
GradeUndervalued
TypeValue
Dividend Yield2.68%
Risk Assessment
Beta0.01
Volatility43.83%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.